Salts and Derivatives of Active Pharmaceutical Ingredients (API)

The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances. At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.

Found 79473 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"

Purity (%)

100

products per page.

+ Info
Irinotecan Related Compound C (11-Ethyl-4-hydroxy-4-methyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl (1,4'-bipiperidine)- 1'-carboxylate hydrochloride)
CAS:
- 3077786-22-9
Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoi
Formula:C₃₂H₃₆N₄O₆·HCl
Color and Shape:Yellow Powder
Molecular weight:608.24016
Ref: 45-1347642
+ Info
Leflunomide Related Compound A (4-(trifluoromethyl)aniline)
CAS:
- 455-14-1
Toluidines (aminotoluenes) and their derivatives, salts thereof
Formula:C₇H₆F₃N
Color and Shape:White Light Yellow Liquid
Molecular weight:161.04523
Ref: 45-1357045
+ Info
Famciclovir Related Compound B (4-(2-Amino-9H-purin-9-yl)-2-(hydroxymethyl)butyl acetate)
CAS:
- 104227-88-5
Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi
Formula:C₁₂H₁₇N₅O₃
Color and Shape:Off-White Powder
Molecular weight:279.13314
Ref: 45-1269185
+ Info
Quinapril Related Compound B (3-Isoquinolinecarboxylic acid, 2-[2-[(1-carboxy-3-phenylpropyl)amino]-1-oxopropyl]-1,2,3,4-tetrahydro-,[3S-[2[R*(R*)],3R*]])
CAS:
- 82768-85-2
Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused
Formula:C₂₃H₂₆N₂O₅
Color and Shape:White Powder
Molecular weight:410.47
Ref: 45-1593423
+ Info
Moxifloxacin Related Compound D (1-Cyclopropyl-8-fluoro-6-methoxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid)
CAS:
- 1029364-77-9
Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused, nesoi
Formula:C₂₁H₂₄FN₃O₄
Color and Shape:Yellow Solid
Molecular weight:401.17508
Ref: 45-1448640
+ Info
Cloxacillin Related Compound D (3-(2-Chlorophenyl)-5-methylisoxazole-4-carboxylic acid)
CAS:
- 23598-72-3
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi
Formula:C₁₁H₈ClNO₃
Color and Shape:Powder
Molecular weight:237.64
Ref: 45-1144951
+ Info
Cefuroxime Axetil δ-3-Isomers ((1RS,6R,7R)-1-Acetoxyethyl 3-[(carbamoyloxy)methyl]-7-[(Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylate)
CAS:
- 123458-61-7
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi
Formula:C₂₀H₂₂N₄O₁₀S
Color and Shape:Tan Powder
Molecular weight:510.10566
Ref: 45-1098231
+ Info
Lomustine Related Compound C (1,3-Dicyclohexylurea)
CAS:
- 2387-23-7
Ureines and their derivatives; salts thereof
Formula:C₁₃H₂₄N₂O
Color and Shape:White Powder
Molecular weight:224.18886
Ref: 45-1369442
+ Info
Quazepam Related Compound A (7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-one)
CAS:
- 49606-44-2
Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoi
Formula:C₁₇H₁₁ClF₄N₂O
Color and Shape:Off-White Cream Powder
Molecular weight:370.0496
Ref: 45-1592227
+ Info
Ticagrelor Related Compound B
CAS:
- 1788033-05-5
Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoi
Formula:C₂₃H₂₈F₂N₆O₄S
Color and Shape:White Off-White Crystalline Powder
Molecular weight:522.18608
Ref: 45-1667133
+ Info
Pancuronium Bromide Related Compound B (1,1'-(17β-Acetoxy-3α-hydroxy-5α-androstan-2β,16β-ylene) bis(1-methylpiperidinium) dibromide)
CAS:
- 41261-71-6
Compounds containing an unfused pyridine ring in the structure, nesoi
Formula:C₃₃H₅₈N₂O₃·2Br
Color and Shape:Off-White Crystalline Powder
Molecular weight:530.44474
Ref: 45-1494239
+ Info
Sulfasalazine Related Compound K (5-{4-[N-(6-Methylpyridin-2-yl)sulfamoyl]phenyldiazenyl}salicylic acid)
CAS:
- 42753-55-9
Sulfonamides, nesoi
Formula:C₁₉H₁₆N₄O₅S
Color and Shape:Yellow Powder
Molecular weight:412.42
Ref: 45-1636118
+ Info
Rabeprazole Related Compound D (2-({[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methyl}sulfonyl)benzimidazole)
CAS:
- 117976-47-3
Compounds containing an unfused pyridine ring in the structure, nesoi
Formula:C₁₈H₂₁N₃O₄S
Color and Shape:White Light Yellow Powder
Molecular weight:375.12528
Ref: 45-1598053
+ Info
Oxymetazoline Related Compound A (N-(2-Aminoethyl)-2-[4-(tert-butyl)-3-hydroxy-2,6-dimethylphenyl]acetamide hydrochloride)
CAS:
- 1391053-50-1
Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereof
Formula:C₁₆H₂₆N₂O₂·HCl
Color and Shape:White Off-White Powder
Molecular weight:314.17611
Ref: 45-1486015
+ Info
Nicotine Related Compound B (3-(1-methyl-1H-pyrrol-2-yl)pyridine)
CAS:
- 487-19-4
Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoi
Formula:C₁₀H₁₀N₂
Color and Shape:Colorless Light Yellow Oily Liquid
Molecular weight:158.21
Ref: 45-1463337
+ Info
Modafinil Related Compound A (2-[(diphenylmethyl)sulfinyl]acetic acid)
CAS:
- 63547-24-0
Other aromatic organo-sulfur compounds (excluding pesti
Formula:C₁₅H₁₄O₃S
Color and Shape:Off-White Powder
Molecular weight:274.06637
Ref: 45-1445346
+ Info
2-Mononitroglycerin
CAS:
- 620-12-2
Esters of other inorganic acids of nonmetals & their salts, their halogenated/sulfonated/nitrated/nitrosated derivs, except of hydrogen halides, nesoi
Formula:C₃H₇NO₅
Color and Shape:Clear Colorless Liquid
Molecular weight:137.03242
Ref: 45-1445584
+ Info
Bisoprolol Related Compound E (3,3'-(Isopropylazanediyl)bis(1-(4-((2-isopropoxyethoxy)methyl)phenoxy)propan-2-ol))
CAS:
- 2775292-22-1
Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoi
Formula:C₃₃H₅₃NO₈
Color and Shape:Colorless Gummy Liquid
Molecular weight:591.37712
Ref: 45-1075804
+ Info
Poloxamer Solid
CAS:
- 9003-11-6
Nonionic surface-active agents,aromatic or modified aromatic,whether or not put up for retail sale
Formula:HO(C₂H₄O)a(C₃H₆O)b(C₂H₄O)aH
Color and Shape:White Cream Powder
Molecular weight:304.2931
Ref: 45-1546161
+ Info
Ecamsule Related Compound C (terephthalic acid)
CAS:
- 100-21-0
Terephthalic acid and its salts
Formula:C₈H₆O₄
Color and Shape:White Off-White Solid
Molecular weight:166.13
Ref: 45-1231637

Salts and Derivatives of Active Pharmaceutical Ingredients (API)

Found 79473 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"

Irinotecan Related Compound C (11-Ethyl-4-hydroxy-4-methyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl (1,4'-bipiperidine)- 1'-carboxylate hydrochloride)

Ref: 45-1347642

Leflunomide Related Compound A (4-(trifluoromethyl)aniline)

Ref: 45-1357045

Famciclovir Related Compound B (4-(2-Amino-9H-purin-9-yl)-2-(hydroxymethyl)butyl acetate)

Ref: 45-1269185

Quinapril Related Compound B (3-Isoquinolinecarboxylic acid, 2-[2-[(1-carboxy-3-phenylpropyl)amino]-1-oxopropyl]-1,2,3,4-tetrahydro-,[3S-[2[R*(R*)],3R*]])

Ref: 45-1593423

Moxifloxacin Related Compound D (1-Cyclopropyl-8-fluoro-6-methoxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid)

Ref: 45-1448640

Cloxacillin Related Compound D (3-(2-Chlorophenyl)-5-methylisoxazole-4-carboxylic acid)

Ref: 45-1144951

Cefuroxime Axetil δ-3-Isomers ((1RS,6R,7R)-1-Acetoxyethyl 3-[(carbamoyloxy)methyl]-7-[(Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylate)

Ref: 45-1098231

Lomustine Related Compound C (1,3-Dicyclohexylurea)

Ref: 45-1369442

Quazepam Related Compound A (7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-one)

Ref: 45-1592227

Ticagrelor Related Compound B

Ref: 45-1667133

Pancuronium Bromide Related Compound B (1,1'-(17β-Acetoxy-3α-hydroxy-5α-androstan-2β,16β-ylene) bis(1-methylpiperidinium) dibromide)

Ref: 45-1494239

Sulfasalazine Related Compound K (5-{4-[N-(6-Methylpyridin-2-yl)sulfamoyl]phenyldiazenyl}salicylic acid)

Ref: 45-1636118

Rabeprazole Related Compound D (2-({[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methyl}sulfonyl)benzimidazole)

Ref: 45-1598053

Oxymetazoline Related Compound A (N-(2-Aminoethyl)-2-[4-(tert-butyl)-3-hydroxy-2,6-dimethylphenyl]acetamide hydrochloride)

Ref: 45-1486015

Nicotine Related Compound B (3-(1-methyl-1H-pyrrol-2-yl)pyridine)

Ref: 45-1463337

Modafinil Related Compound A (2-[(diphenylmethyl)sulfinyl]acetic acid)

Ref: 45-1445346

2-Mononitroglycerin

Ref: 45-1445584

Bisoprolol Related Compound E (3,3'-(Isopropylazanediyl)bis(1-(4-((2-isopropoxyethoxy)methyl)phenoxy)propan-2-ol))

Ref: 45-1075804

Poloxamer Solid

Ref: 45-1546161

Ecamsule Related Compound C (terephthalic acid)

Ref: 45-1231637

Quinapril Related Compound B (3-Isoquinolinecarboxylic acid, 2-[2-[(1-carboxy-3-phenylpropyl)amino]-1-oxopropyl]-1,2,3,4-tetrahydro-,[3S-[2[R(R)],3R*]])